Lipocine
LPCN
#9710
Rank
A$76.8 M
Marketcap
A$13.83
Share price
4.59%
Change (1 day)
181.57%
Change (1 year)

Market capitalization of Lipocine (LPCN)

Market cap: A$76.8 Million

As of February 2026 Lipocine has a market cap of A$76.8 Million. This makes Lipocine the world's 9710th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Lipocine from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026A$76.8 M77.18%
2025A$43.35 M5.92%
2024A$40.92 M88%
2023A$21.76 M-57.93%
2022A$51.74 M-57.13%
2021A$0.12 B3.89%
2020A$0.11 B461.31%
2019A$20.69 M-48.39%
2018A$40.1 M-57.06%
2017A$93.39 M0.18%
2016A$93.22 M-71.21%
2015A$0.32 B293.79%
2014A$82.23 M-29.82%
2013A$0.11 B

End of Day market cap according to different sources

On Feb 22nd, 2026 the market cap of Lipocine was reported to be:

A$76.8 Million
by Nasdaq info icon info icon
A$76.8 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Seagen
SGEN
A$60.92 B 79,215.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
A$14.77 B 19,130.57%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Agile Therapeutics
AGRX
A$14.71 M-80.84%๐Ÿ‡บ๐Ÿ‡ธ USA